Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease : result of the COVID-19-GEAS patient survey
© 2021 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved..
INTRODUCTION: The objetive of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey.
MATERIAL AND METHODS: Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population.
RESULTS: A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and caucasian (82%), with a mean age of 48 years. The most frequent SAEs were Behçet's disease followed by sarcoidosis and systemic lupus erythematosus. 46% of the patients were receiving corticosteroid treatment at a mean prednisone dose of 11 mg/day. Regarding infection, 14 (50%) patients reported symptoms compatible with SARS-CoV-2 infection. RT-PCR was performed on the nasopharyngeal smear in two patients and in one of them (4%) it was positive.
CONCLUSIONS: Both asymptomatic and symptomatic COVID-19 patients with ASD-associated UNI had received similar immunosuppressive treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
Archivos de la Sociedad Espanola de Oftalmologia - 96(2021), 7 vom: 01. Juli, Seite 347-352 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes |
|---|
| Beteiligte Personen: |
Fanlo, P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-TNF-alpha therapy |
|---|
| Anmerkungen: |
Date Revised 28.04.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.oftal.2020.12.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33170630X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33170630X | ||
| 003 | DE-627 | ||
| 005 | 20231225214043.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.oftal.2020.12.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1105.xml |
| 035 | |a (DE-627)NLM33170630X | ||
| 035 | |a (NLM)34629695 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Fanlo, P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease |b result of the COVID-19-GEAS patient survey |
| 246 | 3 | 3 | |a Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a INTRODUCTION: The objetive of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey | ||
| 520 | |a MATERIAL AND METHODS: Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population | ||
| 520 | |a RESULTS: A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and caucasian (82%), with a mean age of 48 years. The most frequent SAEs were Behçet's disease followed by sarcoidosis and systemic lupus erythematosus. 46% of the patients were receiving corticosteroid treatment at a mean prednisone dose of 11 mg/day. Regarding infection, 14 (50%) patients reported symptoms compatible with SARS-CoV-2 infection. RT-PCR was performed on the nasopharyngeal smear in two patients and in one of them (4%) it was positive | ||
| 520 | |a CONCLUSIONS: Both asymptomatic and symptomatic COVID-19 patients with ASD-associated UNI had received similar immunosuppressive treatment | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anti-TNF-alpha therapy | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Corticosteroids | |
| 650 | 4 | |a Immunosuppression | |
| 650 | 4 | |a Uveitis | |
| 700 | 1 | |a Espinosa, G |e verfasserin |4 aut | |
| 700 | 1 | |a Adán, A |e verfasserin |4 aut | |
| 700 | 1 | |a Arnáez, R |e verfasserin |4 aut | |
| 700 | 1 | |a Fonollosa, A |e verfasserin |4 aut | |
| 700 | 1 | |a Heras, H |e verfasserin |4 aut | |
| 700 | 1 | |a Oteiza, J |e verfasserin |4 aut | |
| 700 | 1 | |a Del Carmelo Gracia Tello, B |e verfasserin |4 aut | |
| 700 | 1 | |a Comet, L Sáez |e verfasserin |4 aut | |
| 700 | 1 | |a Pallarés, L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archivos de la Sociedad Espanola de Oftalmologia |d 1992 |g 96(2021), 7 vom: 01. Juli, Seite 347-352 |w (DE-627)NLM012855596 |x 1989-7286 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2021 |g number:7 |g day:01 |g month:07 |g pages:347-352 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.oftal.2020.12.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2021 |e 7 |b 01 |c 07 |h 347-352 | ||